CBS 2019
CBSMD教育中心
中 文

ASCVD Prevention

Abstract

Recommended Article

How Far We Have Come, How Far We Have Yet to Go in Atherosclerosis Research SR-B1 Drives Endothelial Cell LDL Transcytosis via DOCK4 to Promote Atherosclerosis Lipoprotein(a) in Alzheimer, Atherosclerotic, Cerebrovascular, Thrombotic, and Valvular Disease: Mendelian Randomization Investigation Association of Circulating Monocyte Chemoattractant Protein-1 Levels With Cardiovascular Mortality: A Meta-analysis of Population-Based Studies Initial Invasive or Conservative Strategy for Stable Coronary Disease Use of Risk Assessment Tools to Guide Decision-Making in the Primary Prevention of Atherosclerotic Cardiovascular Disease : A Special Report From the American Heart Association and American College of Cardiology MINOCA: a heterogenous group of conditions associated with myocardial damage Association Between Depressive Symptoms and Incident Cardiovascular Diseases

Review Article2020 Apr 24;126(9):1107-1111.

JOURNAL:Circ Res. Article Link

How Far We Have Come, How Far We Have Yet to Go in Atherosclerosis Research

P Libby , KE Bornfeldt. Keywords: allergy and immunology; atherosclerosis; CAD; endothelium; thrombosis.

Full Text PDF